Back to Treatments

Treatment

Aflibercept

1
Conditions
280
Trials
50K
Participants
45%
Average Safety

Condition Evidence

Macular Degeneration

280 trials · 50K participants

90% effectiveness · 45% safety
Aflibercept | DFDA